Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Jayashree Thorat"'
Autor:
Jayashree Thorat, Surabhi Bhat, Manju Sengar, Akshay Baheti, Sweta Bothra, Maheema Bhaskar, Sandeep Prakashnarain Tandon, Sanjay K. Biswas, Gaurav V. Salunke, George Karimundackal, Virendra Kumar Tiwari, C.S. Pramesh, Neha Sharma, Venkatesh Kapu, Thomas Eipe, Bhausaheb Pandurang Bagal, Lingaraj Nayak, Avinash Bonda, Amit Janu, Alok Shetty, Hasmukh Jain
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEFebrile neutropenia (FN) is a serious complication in hematologic malignancies, and lung infiltrates (LIs) remain a significant concern. An accurate microbiological diagnosis is crucial but difficult to establish. To address this, we analyzed
Externí odkaz:
https://doaj.org/article/1d5a23b52e0f43fa840bec692254207e
Autor:
Arihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, Nikita Mehra, Uday Yanamandra, Smita Kayal, Sharat Damodar, Joseph M. John, Prashant Mehta, Suvir Singh, Pritesh Munot, Sushil Selvarajan, Venkatraman Radhakrishnan, Deepesh Lad, Rajan Kapoor, Biswajit Dubashi, Ram S. Bharath, Hasmukh Jain, P. K. Jayachandran, Jeyaseelan Lakshmanan, Thenmozhi Mani, Jayashree Thorat, Satyaranjan Das, Omprakash Karunamurthy, Biju George, Manju Sengar, Pankaj Malhotra
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-5 (2022)
Externí odkaz:
https://doaj.org/article/d76cc7db04ff43e4aed62e7c0c52626a
Autor:
Suresh Kumar Bondili, Bhausaheb Bagal, Abhinav Zawar, Pradeep Ventrapati, Jayashree Thorat, Anant Gokarn, Sachin Punatar, Lingaraj Nayak, Avinash Bonda, Hashmukh Jain, Manju Sengar, Navin Khattry
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 361-367 (2021)
PURPOSEThe prognosis of relapsed and refractory multiple myeloma (RRMM) that is refractory to bortezomib and lenalidomide is very poor wherein the median survival is between 3 and 9 months. We did this retrospective analysis to study the pattern of u
Externí odkaz:
https://doaj.org/article/fb2754aebd0d47ab94f65b5b6f8c96df
Autor:
Hasmukh Jain, Karthik Rengaraj, Vibhor Sharma, Avinash Bonda, Raajit Chanana, Jayashree Thorat, Ashwini Ronghe, Sanjay Biswas, Lingaraj Nayak, Prashant Tembhare, Papagudi Subramnian, Dhanalaxmi Shetty, Nikhil Patkar, Bhausaheb Bagal, Manju Sengar
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1684-1695 (2020)
PURPOSEInfections remain a major challenge in the treatment of acute myeloid leukemia (AML). Induction-related mortality reported in the literature is approximately < 5% in clinical trials. However, the real-world scenario is different, especially in
Externí odkaz:
https://doaj.org/article/cc94cff9e89c40948eeeb3bdaa41bbf0
Autor:
Hasmukh Jain, Ajay Singh, Manju Sengar, Thomas Eipe, Hiral Mehta, Bhausaheb Bagal, Jayashree Thorat, Lingaraj Nayak, Neha Sharma
Publikováno v:
HemaSphere, Vol 6, Pp 2-2 (2022)
Externí odkaz:
https://doaj.org/article/28e62dad73ce48d682ac376a49aa6752
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 190-196 (2019)
The discovery of Philadelphia (Ph) chromosome in 1959 was a landmark moment in the history of targeted therapies for cancer. The BCR-ABL fusion gene formed as a result of this translocation is the key pathogenetic event of chronic myeloid leukemia (C
Externí odkaz:
https://doaj.org/article/216cfbcde5ee4f44a93f0a1bf735f6e3
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 139-140 (2020)
Externí odkaz:
https://doaj.org/article/d1061e119a0f4acc8129108845d602d1
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 270-271 (2019)
Externí odkaz:
https://doaj.org/article/273ab57ff4df4c2599149c3b5951a9d3
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 2, Iss 2, Pp 261-262 (2019)
Externí odkaz:
https://doaj.org/article/c0ab61fbcd44452ebca4a9647fd3502a
Autor:
Swaratika Majumdar, Neha Sharma, Manju Sengar, Jayashree Thorat, Lingaraj Nayak, Avinash Bonda, Bhausaheb Bagal, Akhil Rajendra, Amit Sethi, Hasmukh Jain
Publikováno v:
Leukemia & Lymphoma. 64:628-638